Results 21 to 30 of about 45,263 (167)

Effect of atorvastatin on hs‐CRP in acute coronary syndrome [PDF]

British Journal of Clinical Pharmacology, 2008
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Markers of inflammation are being investigated as predictors of coronary ischaemic events. All major statins have shown almost similar and significant efficacy in reducing C‐reactive protein (CRP) concentrations in acute coronary syndrome (ACS), but atorvastatin was used in a high dose (80 mg).• This study ...
Ankur, Gupta, Dinesh K, Badyal, Prem P, Khosla, Bharti, Uppal, Thannikot M, Jaison, Sandeep, Chopra   +5 more
openaire   +2 more sources

Relationship of HS CRP and sacroiliac joint inflammation in undifferentiated spondyloarthritis [PDF]

Open Medicine, 2018
Abstract Objective Elevation of serum high sensitivity C-reactive protein (hs-CRP) level has been demonstrated as a risk factor for varying diseases, as well as a biomarker for predicting recovery after operation of lumber disc herniation.
Liu Te-Jung, Chang Cheng-Chiang, Chen Liang-Cheng, Chu Heng-Yi, Hsu Chun-Sheng, Chang Shin-Tsu   +5 more
openaire   +3 more sources

Association of Elevated Levels of Inflammatory Marker High-Sensitivity C-Reactive Protein and Hypertension

Journal of Primary Care & Community Health, 2020
Introduction The correlation between inflammation and vascular disease is widely accepted. High levels of C-reactive protein (CRP) have been shown to play a role in the process of endothelial dysfunction.
Sharmila Bisaria, Vittorio Terrigno, Krystal Hunter, Satyajeet Roy   +3 more
doaj   +1 more source

Evaluation of relationship between markers of inflammation and blood pressure in subjects attending OPD in a tertiary care center in Chennai

National Journal of Physiology, Pharmacy and Pharmacology, 2023
Background: The incidence and prevalence of hypertension have been increasing steadily in the present era. Inflammation is a proven key factor in the pathogenesis of hypertension.
Hemalatha P, Prince Johnson Samuel
doaj   +1 more source

Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Mediators of Inflammation, 2022
Background. Several studies have reported that statins have anti-inflammatory effects. Nevertheless, results of clinical trials concerning the effect of statins on the levels of C-reactive protein (CRP) and high-sensitivity CRP (hs-CRP) have been ...
Tahmineh Kandelouei, Mitra Abbasifard, Danyal Imani, Saeed Aslani, Bahman Razi, Mahdieh Fasihi, Sajad Shafiekhani, Keyhan Mohammadi, Tannaz Jamialahmadi, Željko Reiner, Amirhossein Sahebkar   +10 more
doaj   +1 more source

Relationship between plasma high-sensitivity C-reactive protein and traditional cardiovascular risk factors among active-duty military personnel in the Republic of Serbia [PDF]

Vojnosanitetski Pregled, 2022
Background/Aim. Approximately one-third of individuals with only one cardiovascular (CV) risk factor or without any, as well as 40% of individuals with a concentration of cholesterol less than average, die from CV diseases (CVD).
Ratković Nenad, Pandrc Milena, Perić Vitomir, Stojanović Maja, Rančić Nemanja   +4 more
doaj   +1 more source

Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus

Cardiovascular Diabetology, 2020
Background High-sensitivity C-reactive protein (hs-CRP) elevation frequently occurs in acute myocardial infarction (AMI) and is associated with adverse outcomes.
Claudia Lucci, Nicola Cosentino, Stefano Genovese, Jeness Campodonico, Valentina Milazzo, Monica De Metrio, Maurizio Rondinelli, Daniela Riggio, Maria Luisa Biondi, Mara Rubino, Katia Celentano, Alice Bonomi, Nicolò Capra, Fabrizio Veglia, Piergiuseppe Agostoni, Antonio L. Bartorelli, Giancarlo Marenzi   +16 more
doaj   +1 more source

Evaluation of HS-CRP and Lipid Profile in COPD

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013
COPD is a major public health problem. More than 50 % of the patients of COPD die because of some cardiovascular event. Traditionally, the risk of CVD is assessed by the presence of dyslipidaemia. Recently, HS-CRP has emerged as a novel risk factor for the CVD assessment.
Anup N. Nillawar, Kedar B. Joshi, Sandip Bharat Patil, Jayshree S. Bardapurkar, Suhas J. Bardapurkar   +4 more
openaire   +3 more sources

Cumulative Exposure to High‐Sensitivity C‐Reactive Protein Predicts the Risk of Cardiovascular Disease

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundOne measurement of hs‐CRP (high‐sensitivity C‐reactive protein) is associated with increased risk of cardiovascular disease (CVD). The objective of this study was to characterize the association of cumulative exposure to increased hs‐CRP with ...
Aitian Wang, Jie Liu, Chunguang Li, Jingli Gao, Xiaolan Li, Shuohua Chen, Shouling Wu, Hui Ding, Haojun Fan, Shike Hou   +9 more
doaj   +1 more source

Correlation of clinical features with hs‑CRP in TRD patients

Experimental and Therapeutic Medicine, 2018
Correlation of clinical features with hypersensitive C-reactive protein (hs-CRP) in patients with treatment-resistant depression (TRD) was investigated. The severity of disease in 103 TRD patients and 103 non-TRD patients was evaluated using the Hamilton Depression Scale (HAMD)-17.
Qiao, Juan, Geng, Deqin, Qian, Liju, Zhu, Xianghua, Zhao, Houfeng   +4 more
openaire   +3 more sources